Join
Live feed
·
INSIDERFilingvia Quantisnow
Atara Biotherapeutics Inc. logo

Chief Accounting Officer Grant-Huerta Yanina sold $22,036 worth of shares (2,414 units at $9.13), decreasing direct ownership by 5% to 49,636 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
ATRA· Atara Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATRA (Atara Biotherapeutics Inc.) and more on Quantisnow.

Chief Accounting Officer Grant-Huerta Yanina sold $22,036 worth of shares (2,414 units at $9.13), decreasing direct ownership by 5% to 49,636 units (SEC Form 4) to cover withholding tax | Quantisnow